DiaMedica Therapeutics Inc (DMAC)

2.58 +0.05 (+1.98%) USD  |  NASDAQ  |  May 01, 16:00
More

DiaMedica Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for DMAC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2021. Upgrade now.
Date Value
April 24, 2024 --
April 18, 2024 --
April 11, 2024 --
March 20, 2024 --
November 14, 2023 --
August 15, 2023 --
June 22, 2023 --
June 21, 2023 --
May 16, 2023 --
March 29, 2023 --
November 10, 2022 --
October 27, 2022 --
Date Value
August 11, 2022 --
July 07, 2022 --
May 05, 2022 --
March 15, 2022 --
February 02, 2022 --
September 27, 2021 --
August 12, 2021 --
June 29, 2021 --
May 06, 2021 --
March 12, 2021 --
March 11, 2021 --
February 17, 2021 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

--
Minimum
Feb 17 2021
--
Maximum
Feb 17 2021
--
Average
--
Median
Feb 17 2021

Revenue Estimates for Next Fiscal Year Benchmarks

NextCure Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade
iBio Inc Upgrade
Theriva Biologics Inc Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade